FDA Inspection 1008996 — Andrew Holden, M.D.
The FDA completed an inspection of Andrew Holden, M.D. on April 7, 2017 in Auckland. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 7, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Auckland (New Zealand)
Additional Details
Clinical Investigator (CI)